These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 4205219)

  • 21. Incidence of resistance to primary and secondary antituberculosis drugs in isolates of M. tuberculosis from cases of pulmonary tuberculosis.
    Kothadia SN; Sengupta SR
    Indian J Chest Dis Allied Sci; 1984; 26(3):163-6. PubMed ID: 6443608
    [No Abstract]   [Full Text] [Related]  

  • 22. [The bacteriological principles of tuberculosis treatments].
    Grosset J
    Rev Prat; 1979 Jun; 29(33):2645-50. PubMed ID: 113863
    [No Abstract]   [Full Text] [Related]  

  • 23. [Secondary drug resistance of Mycobacterium tuberculosis in patients with chronic destructive forms of pulmonary tuberculosis].
    Poliakova AN; Ianovskaia OM; Samuliak ID; Vasilik GV; Matviĭchuk VM
    Vrach Delo; 1977 Jan; (1):97-9. PubMed ID: 403681
    [No Abstract]   [Full Text] [Related]  

  • 24. [Indicators of antibody formation in patients with pulmonary tuberculosis and drug-resistant Mycobacteria].
    Evdokimov VN
    Probl Tuberk; 1988; (9):44-7. PubMed ID: 3148135
    [No Abstract]   [Full Text] [Related]  

  • 25. [Resensitization of resistant mycobacterial strains to antitubercular drugs].
    Vercellino E
    G Mal Infett Parassit; 1968 Feb; 20(2):191-3. PubMed ID: 4984621
    [No Abstract]   [Full Text] [Related]  

  • 26. Primary antituberculosis drug resistance and acquired rifampicin resistance in Gujarat, India.
    Trivedi SS; Desai SG
    Tubercle; 1988 Mar; 69(1):37-42. PubMed ID: 3140458
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Determination of drug sensitivity of Mycobacterium tuberculosis by means of potassium tellurite].
    Kovalev GK
    Antibiotiki; 1969 Apr; 14(4):323-5. PubMed ID: 4977639
    [No Abstract]   [Full Text] [Related]  

  • 28. [Experimental tuberculosis in mice, a model for the study of antitubercular chemotherapy].
    Rist N
    Arch Roum Pathol Exp Microbiol; 1971 Jun; 30(2):295-6. PubMed ID: 5004388
    [No Abstract]   [Full Text] [Related]  

  • 29. [Clinical significance of the degree of resistance of tubercular mycobacteria to specific chemoantibiotics (clinical note)].
    Lucchesi M; Mancini P; Sbampato M
    Ann Ist Carlo Forlanini; 1968; 28(1):74-90. PubMed ID: 4985828
    [No Abstract]   [Full Text] [Related]  

  • 30. The mycobacteriology of pulmonary tuberculosis in South African gold miners.
    Cowie RL
    Tubercle; 1990 Mar; 71(1):39-42. PubMed ID: 2115216
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Short-course treatment regimens for patients with tuberculosis.
    Dutt AK; Stead WW
    Arch Intern Med; 1980 Jun; 140(6):827-9. PubMed ID: 6770770
    [No Abstract]   [Full Text] [Related]  

  • 32. Bacteriologic basis of short-course chemotherapy for tuberculosis.
    Grosset J
    Clin Chest Med; 1980 May; 1(2):231-41. PubMed ID: 6794976
    [No Abstract]   [Full Text] [Related]  

  • 33. [Primary drug resistance to standard drugs in previously untreated patients with pulmonary tuberculosis in Poznań in 1966-1969].
    Krzyzaniak J; Lubieńska B
    Gruzlica; 1971 Aug; 39(8):742-6. PubMed ID: 5097535
    [No Abstract]   [Full Text] [Related]  

  • 34. [Antitubercular effect of capreomycin in vitro].
    Janowiec M
    Gruzlica; 1969 Jul; 37(7):629-35. PubMed ID: 4981783
    [No Abstract]   [Full Text] [Related]  

  • 35. [Comparative results of treatment of pulmonary tuberculosis with the compounds of benzoyl-PAS-Ca-isoniazide and streptomycin-isoniazid].
    Favez G; Gonin JD; Gubéran E; de Kalbermatten JP; Vulliémoz P; Willa C
    Schweiz Med Wochenschr; 1969 Feb; 99(5):150-6. PubMed ID: 4974643
    [No Abstract]   [Full Text] [Related]  

  • 36. [A study on prevalence of resistance to major drugs among newly admitted pulmonary tuberculosis patents in 1972. Part 1. Comparison of result in 1972 with those in 1957, '59, '61, '63, '66 and '69].
    Kekkaku; 1975 Jan; 50(1):1-8. PubMed ID: 805311
    [No Abstract]   [Full Text] [Related]  

  • 37. [Resistance to antitubercular drugs in Chile].
    Valenzuela MT; Scheel G; Ponce J; Lepe R; Velasco M; Valenzuela P
    Rev Med Chil; 1984 Jan; 112(1):76-80. PubMed ID: 6429808
    [No Abstract]   [Full Text] [Related]  

  • 38. [Studies of the polychemoresistance of Mycobacterium tuberculosis].
    Curci G; De Franciscis V; Giuliano V
    Arch Monaldi; 1970; 25(2):99-114. PubMed ID: 4994908
    [No Abstract]   [Full Text] [Related]  

  • 39. [Mechanisms of the action of drugs in the short-course chemotherapy].
    Mitchison DA
    Bull Int Union Tuberc; 1985; 60(1-2):36-40. PubMed ID: 2416374
    [No Abstract]   [Full Text] [Related]  

  • 40. Drug resistance in M. tuberculosis cultures determined by the Steenken MIC and Canetti proportion tests.
    Montalbine V; Collins FM; Doster B
    Int Z Klin Pharmakol Ther Toxikol; 1970 Jan; 3(1):78-80. PubMed ID: 4985844
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.